From corticosteroids to Anti-TNF treatments, when dependence takes over

被引：0
|
作者：
Bourreille, A [1 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2004年 / 28卷 / 8-9期
关键词：
D O I：
10.1016/S0399-8320(04)95049-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：696 / 698
页数：3
相关论文
共 50 条
  • [1] Monitoring of anti-TNF biological treatments
    A Ruiz del Agua
    D Pascual-Salcedo
    A Balsa
    I Ramos
    L Novalbos
    S Ramiro
    A Martínez
    L Simón
    D Nagore
    Journal of Translational Medicine, 8 (Suppl 1)
  • [2] FDA perspective on anti-TNF treatments
    Schwieterman, WD
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 90 - 91
  • [3] Dermatological complications and safety of anti-TNF treatments
    Kerbleski, Joseph F.
    Gottlieb, Alice B.
    GUT, 2009, 58 (08) : 1033 - 1039
  • [4] Anti-TNF mab/corticosteroids/DMARDsVarious toxicities: case report
    Reactions Weekly, 2011, 1357 (1) : 6 - 6
  • [5] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [6] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [7] ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
    Chiorean, Michael
    Afzali, Anita
    Cross, Raymond
    Zhou, Zhou
    Macaulay, Dendy
    Ganguli, Arijit
    Wang, Anthony
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S51 - S52
  • [8] Local experience of switching anti-TNFα treatments for rheumatoid arthritis
    Smale, S. W.
    Amos, N.
    Morgans, G. L.
    Lewis, K. E.
    Camilleri, J. P.
    RHEUMATOLOGY, 2007, 46 : I31 - I31
  • [9] COMBINATION OF ACTIVE AND PASSIVE ANTI-TNFα TREATMENTS IN HUMAN-TNFα TRANSGENIC MICE
    Semerano, Luca
    Biton, Jerome
    Delavallee, Laure
    Duvallet, Emilie
    Bernier, Emilie
    Grouard-Vogel, Geraldine
    Boissier, Marie-Christophe
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A70 - A70
  • [10] ADALIMUMAB IN PSORIATIC ARTHRITIS WHEN OTHER ANTI-TNF FAIL
    Lopez-Moyado, A. L.
    Cervantes-Solano, J., I
    Rodrigues-Tamariz, W. L.
    Banuelos-Ramirez, D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S73 - S74
12345